STRATA CRITICAL MEDICAL, INC. Payments to Acquire Held-to-maturity Securities
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Payments to Acquire Held-to-maturity Securities of $6.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for the quarter ending 2026-06-30 was $6.25M, a 48.76% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for the quarter ending 2025-09-30 was $49.85M, a 24.13% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for fiscal 2025 was $146.26M, a 2.10% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for fiscal 2024 was $143.25M, a 46.11% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for fiscal 2023 was $265.83M, a 16.96% increase from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. payments to acquire held-to-maturity securities for fiscal 2022 was $227.29M.
| Period end | Payments to Acquire Held-to-maturity Securities 3 month | Payments to Acquire Held-to-maturity Securities 6 month | Payments to Acquire Held-to-maturity Securities 9 month | Payments to Acquire Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.25M 10-Q · filed 2026-08-04 | $6.25M derived: sum of 3 quarters · filed 2026-08-04 | $56.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $49.85M derived: sum of 3 quarters · filed 2026-05-06 | $62.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $49.85M derived: sum of 2 quarters · filed 2026-03-03 | $62.06M derived: sum of 3 quarters · filed 2026-08-04 | $146.26M 10-K · filed 2026-03-03 |
| 2025-09-30 | $49.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $62.06M derived: sum of 2 quarters · filed 2026-08-04 | $146.26M 10-Q · filed 2025-11-10 | $146.75M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $12.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $96.40M 10-Q · filed 2026-08-04 | $96.89M derived: sum of 3 quarters · filed 2026-08-04 | $162.61M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $84.20M 10-Q · filed 2026-05-06 | $84.69M derived: sum of 2 quarters · filed 2026-05-06 | $150.40M derived: sum of 3 quarters · filed 2026-05-06 | $150.40M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $489.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $66.20M derived: sum of 2 quarters · filed 2026-03-03 | $66.20M derived: sum of 3 quarters · filed 2026-03-03 | $143.25M 10-K · filed 2026-03-03 |
| 2024-09-30 | $65.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $65.72M derived: sum of 2 quarters · filed 2025-11-10 | $142.77M 10-Q · filed 2025-11-10 | $142.77M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $77.05M 10-Q · filed 2025-08-05 | $77.05M derived: sum of 3 quarters · filed 2025-08-05 | $212.74M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $77.05M 10-Q · filed 2025-05-12 | $77.05M derived: sum of 2 quarters · filed 2025-05-12 | $212.74M derived: sum of 3 quarters · filed 2025-05-12 | $212.74M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $135.69M derived: sum of 2 quarters · filed 2025-03-13 | $135.69M derived: sum of 3 quarters · filed 2025-03-13 | $265.83M 10-K · filed 2025-03-13 |
| 2023-09-30 | $135.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $135.69M derived: sum of 2 quarters · filed 2024-11-12 | $265.83M 10-Q · filed 2024-11-12 | $353.21M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $130.15M 10-Q · filed 2024-08-08 | $217.52M derived: sum of 3 quarters · filed 2024-08-08 | $357.43M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $130.15M 10-Q · filed 2024-05-07 | $217.52M derived: sum of 2 quarters · filed 2024-05-07 | $357.43M derived: sum of 3 quarters · filed 2024-05-07 | $357.43M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $87.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $227.29M derived: sum of 2 quarters · filed 2024-03-12 | $227.29M derived: sum of 3 quarters · filed 2024-03-12 | $227.29M 10-K · filed 2024-03-12 |
| 2022-09-30 | $139.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $139.91M derived: sum of 2 quarters · filed 2023-11-08 | $139.91M 10-Q · filed 2023-11-08 | $139.91M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |